Keywords: Optimer Pharma, Optimer Biotech, Sale of equity stake, Dificid, CDAD, Diarrhea

Optimer Pharma to sell remaining stake in Optimer Biotech for $60 million

Article | 08 October 2012

San Diego, USA-based Optimer Pharmaceuticals (Nasdaq: OPTR) yesterday announced the sale of its stake in Optimer Biotechnology (OBI) to current ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Optimer Biotechnology

Optimer Pharmaceuticals

Go to company listing

Related Drugs

Dificid

Go to drug listing